Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cantor Fitzgerald
Johnson and Johnson
Harvard Business School
Chinese Patent Office
US Department of Justice
Farmers Insurance
Daiichi Sankyo
Federal Trade Commission

Generated: February 20, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 080431

« Back to Dashboard

NDA 080431 describes METARAMINOL BITARTRATE, which is a drug marketed by Abraxis Pharm, Elkins Sinn, Fresenius Kabi Usa, and Gd Searle Llc, and is included in four NDAs. Additional details are available on the METARAMINOL BITARTRATE profile page.

The generic ingredient in METARAMINOL BITARTRATE is metaraminol bitartrate. There is one drug master file entry for this compound. Additional details are available on the metaraminol bitartrate profile page.
Summary for 080431
Applicant:Abraxis Pharm
Ingredient:metaraminol bitartrate
Therapeutic Class:Cardiovascular Agents
Formulation / Manufacturing:see details
Medical Subject Heading (MeSH) Categories for 080431

Profile for product number 001

Approval Date:Approved Prior to Jan 1, 1982TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Army
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.